The aim of this study was to investigate the diagnostic approach to recently diagnosed hypertensive patients by primary care physicians in Italy and to find out whether general practitioners manage these patients according to 1999 WHO/ISH guideline recommendations. In total, 228 consecutive patients (117 men and 111 women, mean age 51712 years) with recently diagnosed hypertension (o2 years) referred for the first time to six outpatient hypertension centres throughout Italy were included in the study. The primary care physicians' approach was evaluated during the specialist visit by a specific questionnaire containing detailed questions about diagnostic work-up and treatment made at the time of the first diagnosis of hypertension. At the study visit, 71% of the patients were on treatment with antihypertensive drugs and 18.7% of them had blood pressure (BP) values lower than 140/90 mmHg. A complete clinical and laboratory evaluation according to the minimum work-up suggested by the guidelines had been carried out in only 10% of the patients. A full physical examination had been performed in 60% of the patients, electrocardiogram in 54%, serum total cholesterol in 53%, glucose in 49%, creatinine in 49%, urine analysis in 46%, potassium in 42%, and fundus oculi in 19%. Additional investigations such as ambulatory BP monitoring, echocardiogram, carotid ultrasonogram, and microalbuminuria had been carried out in a minority of patients (21, 18, 9, and 3%, respectively). The impact on hypertension guidelines on patients' management in everyday primary care practice appears marginal. Thus, our findings indicate that the majority of general practitioners manage hypertensive patients according to a simple BP-based approach rather than a more integrated approach based on global risk stratification.
Introduction
Prospective studies clearly identified an increasing risk for cardiovascular disease, stroke and renal failure associated with progressively higher levels of both systolic and diastolic blood pressure (BP). [1] [2] [3] Results of several randomised, controlled clinical trials have shown that antihypertensive drug treatment is associated with reductions in morbidity and mortality by cardiovascular and renal disease. [4] [5] [6] [7] According to this evidence, guidelines have been prepared, and the pharmacological and non-pharmacological treatment of hypertensive patients has been recommended. One of the most relevant questions is when to initiate pharmacological therapy. In previous guidelines, initiation of antihypertensive treatment was recommended simply on the basis of BP levels, as elevated BP was considered an important indicator of the relative risk of cardiovascular disease. 8, 9 However, the absolute benefits of antihypertensive therapy depend not only on BP but also on the presence of additional cardiovascular risk factors and preexisting cardiovascular and renal diseases. 10 The 1999 WHO/ISH Hypertension Guidelines, the most recent set of guidelines in the field of arterial hypertension, emphasise the importance of the absolute, as opposed to the relative risk in decision making, and for this purpose they suggest a simple method to evaluate the absolute risk of major cardiovascular events. 11 The estimates are based on systolic (SBP) and diastolic (DBP) blood pressure, risk factors such as age, smoking, serum cholesterol, family history of premature cardiovascular disease, diabetes, target organ damage (TOD) and history or clinical evidence of cardiovascular complications. According to this algorithm, four categories of absolute cardiovascular risk (low, medium, high and very high) may be obtained by a careful medical history, physical examination and routine work-up recommended by WHO/ISH. This comprehensive risk stratification strategy in primary and secondary prevention is crucial in order to improve the benefit of anti-hypertensive treatment. 12 However, it has been demonstrated that a large fraction of physicians do not accurately assess patients' risk of cardiovascular events according to these recommendations. 13 The purpose of the present investigation was to assess the diagnostic and therapeutic approach to newly diagnosed hypertensive patients by primary care physicians in Italy, in order to find out whether general practitioners treat hypertensive patients according to the level of BP or a more comprehensive risk stratification strategy.
Methods
Eight outpatient hypertension hospital centres throughout Italy were asked to participate in the project. After agreement to participate in the study, the first 40 consecutive patients with recent diagnosis of hypertension (o2 years) and referred by their general practitioners or self-referred for the first time to each specialist centre had to be included in the survey. BP was measured in the outpatient clinic by a physician with a mercury sphygmomanometer (first and fifth phases of Koroktoff sounds taken as SBP and DBP, respectively) after the subjects had rested for 5-10 min in the sitting position. Three measurements were taken at 1 min intervals and the average was used to define clinic SBP and DBP. A questionnaire was filled in, including the reason for the visit, medical history (with detailed questions on the time, modality of diagnosis of hypertension and on BP levels measured at the time of discovery), clinical and laboratory investigations previously performed according to the minimum diagnostic work-up recommended by the 1999 WHO/ISH guidelines, additional examinations, drugs used, and cardiovascular risk factors. We included only patients with both the referral letter containing some information about previous clinical tests and the results of these examinations. Exclusion criteria from the study were unreliable patients' answers to the items included in the questionnaire and unavailable written documentation. We evaluated the physicians' approaches to the management of hypertension using, as standard reference, the recommendations of WHO/ISH for the initial work-up in all hypertensive patients. The guidelines suggest that a correct evaluation of the hypertensive patient should be accomplished by a careful medical history, physical examination, fundus oculi and routine laboratory investigations including at least urinalysis, serum potassium, creatinine, fasting glucose, total cholesterol and 12-lead electrocardiogram.
Statistical analysis
Data are expressed as means 7 s.d. or percentage. The statistical analysis was mainly descriptive and consisted of means and standard deviations for continuous variables, and numbers and percentages for discrete variables. Means were compared using the Student's t-test for independent samples. The w 2 -test was applied to compare proportions. A P-value of o0.05 was considered significant.
Results
A total of eight centres agreed to participate; one of these stopped participating and one did not return the study files. Between March and July 2001, the remaining six centres recruited 240 patients; 12 of these were excluded from further analysis because their study files were not correctly implemented. Of the 228 patients who were included in the study, 117 were men and 111 women ( Table 1 ). The mean age was 51712 years. Clinic BP at study visit was 149718/94710 mmHg. Of the patients 71% were on treatment with antihypertensive drugs; SBP and DBP were normal (o140/90 mmHg) in 18.7% of them. With regard to other risk factors, 27% of the patients were smokers, 22% had hypercholesterolaemia (serum total cholesterol X6.5 mmol/l), 4% were diabetics (fasting plasma glucose X7.8 mmol/l or current antidiabetic therapy), and 5% had cardiovascular or cerebrovascular events. With regard to treatment, 61.5% of the patients were on monotherapy, 28.8% on two drugs, 7.7% on three Table 2 summarises the mean clinic BP measured at the time of the first diagnosis of arterial hypertension, the grade of hypertension according to the definition and classification of BP levels reported in the guidelines, and the prevalence rate of clinical and laboratory investigations carried out by general practitioners in searching for other cardiovascular risk factors, target organ damage (TOD) and secondary hypertension. Overall, only 10% of the patients had a complete clinical and laboratory evaluation performed according to a minimum work-up suggested by the guidelines. A full physical examination was performed in about 60% of the patients, electrocardiogram in 54%, total serum cholesterol in 53%, glucose in 49%, creatinine in 49%, urine analysis in 46%, serum potassium in 42%, fundus oculi in 19% (Figure 1) . Moreover, additional investigations such as ambulatory BP monitoring, echocardiography, carotid ultrasonography, renal ultrasound and microalbuminuria were carried out in 21, 18, 9, 5, and 3%, respectively.
Discussion
The guidelines for diagnosis and treatment of hypertension are important tools to improve the clinical approach of the physician in the daily treatment of hypertensive patients. 9, 14 Guidelines are aimed to provide indications for clinical practice based on rigorous scientific evidence; however, their use in decision making in clinical practice is largely neglected by physicians. 15, 16 The compliance of physicians to evidence-based medicine and to recommendations of guidelines has not been fully investigated. This study was intended to explore the general practitioners' adherence to the WHO/ISH hypertension guidelines in the clinical management of newly diagnosed hypertensive patients. The results indicate that a vast majority of primary care physicians do not carry out the minimum diagnostic work-up recommended by the guidelines. In fact, 17 Correct information about the global cardiovascular risk profile can be easily obtained by an accurate clinical evaluation integrated by some routine investigations. In our survey, however, this relatively simple approach represents an exception rather than a rule. In fact, the data reported herein indicate that hypertension is considered by a large proportion of primary care physicians to be a simple modifiable risk factor and not a complex clinical condition which needs some further clinical and laboratory investigations, aimed to search for TOD, secondary causes of elevated BP and to estimate the absolute risk of future cardiovascular events. The surprising poor compliance to the recommendations of the 1999 WHO/ISH guidelines shown by this study may be related to several factors. In particular, the adherence of the physicians to guidelines is influenced by their knowledge, which has been proved to be largely unsatisfactory. In a survey aimed at estimating the physicians' approaches to the treatment of hypertension in the USA, Hyman and Pavlik demonstrated that 41% of 316 general practitioners were totally or partially unfamiliar with the JNC guidelines. 18 Furthermore, a large fraction of these physicians used higher BP thresholds for the diagnosis and treatment of hypertension than those recommended by all current guidelines. More recently, in a large survey on guidelines awareness conducted in Germany, Hagemeister et al showed that only a quarter of the participating physicians had sufficient guideline-conforming knowledge about the diagnosis and treatment of hypertension. 19 In accordance with the American and German reports were the findings obtained by our group in a small pilot regional survey involving 240 primary care physicians operating in Lombardy (Italy). 20 The data of our survey indicate that a large fraction of newly diagnosed hypertensive patients had been treated with antihypertensive drugs without a minimum work-up aimed to search for coexistent metabolic risk factors, TOD and secondary causes of high BP. The first implication of this approach is that the treatment of the patients was decided simply on the basis of BP criteria (often based on a single BP measurement) rather than on a more comprehensive evaluation of the global risk stratification. This approach is far from the recommendations of the guidelines that state: 'The primary goal of treatment of a patient with high BP is to achieve the maximum reduction in total cardiovascular risky and this requires treatment of all reversible risk factors identifiedy and the appropriate management of associated clinical conditions'. Secondly, an inadequate clinical and laboratory evaluation of patients represents one of the major causes leading to systematic underestimation of secondary hypertension, that is a typical clinical condition often refractory to treatment. Thirdly, the initial antihypertensive therapy should be chosen according to specific individual variables including the cardiovascular risk factor profile, the presence of TOD, clinical cardiovascular disease and diabetes, and the presence of coexisting disorders that may either favour or limit the use of particular antihypertensive drugs. Contrary to what was observed in this study, the physician should tailor the antihypertensive treatment after a complete clinical evaluation, according to a practical framework suggested by the guidelines. Fourthly, the very low prevalence of BP control in treated hypertensives referred to or self-referred to our specialist centres documents that most of the physicians are resistant to intensify treatment in order to achieve the recommended targets of antihypertensive therapy.
This study presents several limitations. First of all, it is not a population-based survey, so that the findings are unlikely to be representative of the general hypertensive population in our country. Another limitation is that the WHO/ISH guidelines with the algorithm for cardiovascular risk stratification have been published from 24 to 28 months before the survey. It should be pointed out, however, that the definition of the absolute risk profile before starting antihypertensive treatment had been clearly recommended by the JNC VI and widely propagated by scientific societies in Italy over the last few years. Furthermore, we investigated the diagnostic workup carried out from the time of first diagnosis of hypertension until the referral visit, so we cannot exclude the fact that patients included in the study underwent routine laboratory investigations for different clinical reasons before the identification of hypertension. A final brief comment concerns the following issues: (1) What is the clinical profile of the patients referred to specialist centres in Italy? (2) Are routine examinations recommended by the WHO/ISH guidelines available in general practice? Only a variable fraction of hypertensives (negligible in small towns and rural areas, greater in mediumsized and large cities) are referred by general practitioners to outpatient specialist centres; in most of these patients the referral appears appropriate, as they have unsatisfactory BP control, TOD, suspected secondary hypertension and refractory hypertension. It is worthy of note, however, that a growing portion of grade I, uncomplicated hypertensives ask their general practitioners for a specialist visit prescription, in order to obtain a more adequate diagnostic and therapeutic work-up. This trend appears unrelated to the availability of routine investigations in primary care, because these tests and additional examinations such as echocardiography, renal ultrasound and ambulatory BP monitoring are easily accessible in a few days or weeks all over Italy.
Conclusion
Although this survey was relatively small, it is one of the few studies aimed at investigating the current diagnostic and therapeutic approach to arterial hypertension by primary care physicians. From the present study, it is evident that the clinical evaluation of newly diagnosed hypertensive subjects is largely different from the recommendations of guidelines and the decisions to treat are based on BP thresholds rather than on global cardiovascular risk assessment. These findings support the need of reinforcing information and education strategies for primary care physicians.
